These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9117562)

  • 1. Acetylcholine receptor targets on cortical pyramidal neurones as targets for Alzheimer's therapy.
    Chessell JP
    Neurodegeneration; 1996 Dec; 5(4):453-9. PubMed ID: 9117562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective loss of cholinergic receptors following unilateral intracortical injection of volkensin.
    Chessell IP; Pearson RC; Heath PR; Bown DM; Francis PT
    Exp Neurol; 1997 Sep; 147(1):183-91. PubMed ID: 9294415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in cortical nicotinic acetylcholine receptor numbers following unilateral destruction of pyramidal neurones by intrastriatal volkensin injection.
    Chessell IP; Francis PT; Bowen DM
    Neurodegeneration; 1995 Dec; 4(4):415-24. PubMed ID: 8846235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localisation of muscarinic (m1) and other neurotransmitter receptors on corticofugal-projecting pyramidal neurones.
    Chessell IP; Francis PT; Pangalos MN; Pearson RC; Bowen DM
    Brain Res; 1993 Dec; 632(1-2):86-94. PubMed ID: 8149248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An aspect of Alzheimer neuropathology after suicide transport damage.
    Chessell IP; Francis PT; Webster MT; Procter AW; Heath PR; Pearson RC; Bowen DM
    J Neural Transm Suppl; 1994; 44():231-43. PubMed ID: 7897395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotransmitter receptors of rat cortical pyramidal neurones: implications for in vivo imaging and therapy.
    Bowen DM; Francis PT; Pangalos MN; Chessell IP
    J Reprod Fertil Suppl; 1993; 46():131-43. PubMed ID: 8391081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Hydroxytryptamine1A but not 5-hydroxytryptamine2 receptors are enriched on neocortical pyramidal neurones destroyed by intrastriatal volkensin.
    Francis PT; Pangalos MN; Pearson RC; Middlemiss DN; Stratmann GC; Bowen DM
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1273-81. PubMed ID: 1534843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Destruction of a sub-population of cortical neurones by suicide transport of volkensin, a lectin from Adenia volkensii.
    Pangalos MN; Francis PT; Pearson RC; Middlemiss DN; Bowen DM
    J Neurosci Methods; 1991 Nov; 40(1):17-29. PubMed ID: 1795550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinic and muscarinic receptor-evoked depolarizations recorded from a novel cortical brain slice preparation.
    Chessell IP; Humphrey PP
    Neuropharmacology; 1995 Oct; 34(10):1289-96. PubMed ID: 8570026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex.
    Kellar KJ; Whitehouse PJ; Martino-Barrows AM; Marcus K; Price DL
    Brain Res; 1987 Dec; 436(1):62-8. PubMed ID: 3690354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent activity in layer 5 pyramidal neurons following cholinergic activation of mouse primary cortices.
    Rahman J; Berger T
    Eur J Neurosci; 2011 Jul; 34(1):22-30. PubMed ID: 21645136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease.
    Araujo DM; Lapchak PA; Robitaille Y; Gauthier S; Quirion R
    J Neurochem; 1988 Jun; 50(6):1914-23. PubMed ID: 3373218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of M1-muscarinic receptors in the excitation of neocortical neurones by acetylcholine.
    Bradshaw CM; Sheridan RD; Szabadi E
    Neuropharmacology; 1987 Aug; 26(8):1195-200. PubMed ID: 2443871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscarinic and nicotinic acetylcholine receptor agonists: current scenario in Alzheimer's disease therapy.
    Verma S; Kumar A; Tripathi T; Kumar A
    J Pharm Pharmacol; 2018 Aug; 70(8):985-993. PubMed ID: 29663387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMDA receptors assessed by autoradiography with [3H]L-689,560 are present but not enriched on corticofugal-projecting pyramidal neurones.
    Pangalos MN; Francis PT; Foster AC; Pearson RC; Middlemiss DN; Bowen DM
    Brain Res; 1992 Nov; 596(1-2):223-30. PubMed ID: 1361417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Location of nicotinic and muscarinic cholinergic and mu-opiate receptors in rat cerebral neocortex: evidence from thalamic and cortical lesions.
    Sahin M; Bowen WD; Donoghue JP
    Brain Res; 1992 May; 579(1):135-47. PubMed ID: 1320443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscarinic cholinoceptive neurons in the frontal cortex in Alzheimer's disease.
    Schröder H; Giacobini E; Struble RG; Luiten PG; van der Zee EA; Zilles K; Strosberg AD
    Brain Res Bull; 1991 Nov; 27(5):631-6. PubMed ID: 1756381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types.
    Perry EK; Smith CJ; Court JA; Perry RH
    J Neural Transm Park Dis Dement Sect; 1990; 2(3):149-58. PubMed ID: 2175197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment.
    Lombardo S; Maskos U
    Neuropharmacology; 2015 Sep; 96(Pt B):255-62. PubMed ID: 25514383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cortical pyramidal neurone neurotransmitter receptor that may affect beta-amyloid precursor protein.
    Chessell IP; Francis PT; Bowen DM
    Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):240S. PubMed ID: 8224396
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.